Follow the people · Insider
Thomas Catinazzo
Thomas Catinazzo files insider transactions with the SEC as a chief financial officer of Relay Therapeutics (RLAY). We hold 11 disclosed purchases and sales filed since 15 December 2020, 4 of them in the last 90 days.
- Files forRLAY
- Disclosed buys and sells11 in all, 4 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 11 December 2020 — 14 August 2026Chief Financial Officer · Relay Therapeutics (RLAY)105 Form 4 lines · source: SEC Form 4
Everything they disclosed
105 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 17,717 shares of Relay TherapeuticsSEC Form 418 August 2026Common Stock · traded 14 August 2026 · filed 18 August 2026
- ▼ sold on the open market 1,459 shares of Relay TherapeuticsSEC Form 430 July 2026Common Stock · traded 28 July 2026 · filed 30 July 2026
- ▼ sold on the open market 17,717 shares of Relay TherapeuticsSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- ▼ sold on the open market 17,717 shares of Relay TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- exercised options over 51,560 shares of Relay Therapeutics (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 22 June 2026 · filed 24 June 2026
- exercised options over 56,323 shares of Relay TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 56,323 shares of Relay TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- exercised options over 61,563 shares of Relay TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 61,563 shares of Relay TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- exercised options over 51,560 shares of Relay TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 51,560 shares of Relay TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- exercised options over 56,323 shares of Relay Therapeutics (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 22 June 2026 · filed 24 June 2026
- exercised options over 61,563 shares of Relay Therapeutics (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 17,717 shares of Relay TherapeuticsSEC Form 414 May 2026Common Stock · traded 14 May 2026 · filed 14 May 2026
- ▼ sold on the open market 972 shares of Relay TherapeuticsSEC Form 430 April 2026Common Stock · traded 28 April 2026 · filed 30 April 2026
- ▼ sold on the open market 17,717 shares of Relay TherapeuticsSEC Form 49 April 2026Common Stock · traded 7 April 2026 · filed 9 April 2026
- exercised options over 1,800 shares of Relay TherapeuticsSEC Form 49 April 2026Common Stock · traded 9 April 2026 · filed 9 April 2026
- ▼ sold on the open market 1,800 shares of Relay TherapeuticsSEC Form 49 April 2026Common Stock · traded 9 April 2026 · filed 9 April 2026
- exercised options over 1,800 shares of Relay Therapeutics (a derivative holding)SEC Form 49 April 2026Stock Option (Right to Buy) · traded 9 April 2026 · filed 9 April 2026
- ▼ sold on the open market 17,717 shares of Relay TherapeuticsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 17,717 shares of Relay TherapeuticsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 13,820 shares of Relay TherapeuticsSEC Form 429 January 2026Common Stock · traded 27 January 2026 · filed 29 January 2026
- ▼ sold on the open market 1,695 shares of Relay TherapeuticsSEC Form 429 January 2026Common Stock · traded 28 January 2026 · filed 29 January 2026
- ▼ sold on the open market 13,820 shares of Relay TherapeuticsSEC Form 429 January 2026Common Stock · traded 27 January 2026 · filed 29 January 2026
- ▼ sold on the open market 1,695 shares of Relay TherapeuticsSEC Form 429 January 2026Common Stock · traded 28 January 2026 · filed 29 January 2026
- was granted 400,000 shares of Relay Therapeutics (a derivative holding)SEC Form 415 January 2026Stock Option (Right to Buy) · traded 13 January 2026 · filed 15 January 2026
- was granted 400,000 shares of Relay Therapeutics (a derivative holding)SEC Form 415 January 2026Stock Option (Right to Buy) · traded 13 January 2026 · filed 15 January 2026
- ▼ sold on the open market 21,664 shares of Relay TherapeuticsSEC Form 430 October 2025Common Stock · traded 28 October 2025 · filed 30 October 2025
- ▼ sold on the open market 1,701 shares of Relay TherapeuticsSEC Form 430 July 2025Common Stock · traded 28 July 2025 · filed 30 July 2025
- ▼ sold on the open market 18,380 shares of Relay TherapeuticsSEC Form 430 July 2025Common Stock · traded 29 July 2025 · filed 30 July 2025
- ▼ sold on the open market 1,709 shares of Relay TherapeuticsSEC Form 430 April 2025Common Stock · traded 28 April 2025 · filed 30 April 2025
- ▼ sold on the open market 981 shares of Relay TherapeuticsSEC Form 430 April 2025Common Stock · traded 28 April 2025 · filed 30 April 2025
- ▼ sold on the open market 3,558 shares of Relay TherapeuticsSEC Form 430 April 2025Common Stock · traded 29 April 2025 · filed 30 April 2025
- ▼ sold on the open market 12,943 shares of Relay TherapeuticsSEC Form 430 April 2025Common Stock · traded 30 April 2025 · filed 30 April 2025
- ▼ sold on the open market 298 shares of Relay TherapeuticsSEC Form 431 March 2025Common Stock · traded 27 March 2025 · filed 31 March 2025
- ▼ sold on the open market 4,566 shares of Relay TherapeuticsSEC Form 431 March 2025Common Stock · traded 27 March 2025 · filed 31 March 2025
- ▼ sold on the open market 33,753 shares of Relay TherapeuticsSEC Form 430 January 2025Common Stock · traded 28 January 2025 · filed 30 January 2025
- ▼ sold on the open market 2,283 shares of Relay TherapeuticsSEC Form 430 January 2025Common Stock · traded 28 January 2025 · filed 30 January 2025
- was granted 139,141 shares of Relay TherapeuticsSEC Form 430 January 2025Common Stock · traded 28 January 2025 · filed 30 January 2025
- ▼ sold on the open market 2,109 shares of Relay TherapeuticsSEC Form 430 January 2025Common Stock · traded 29 January 2025 · filed 30 January 2025
- ▼ sold on the open market 20,791 shares of Relay TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- was granted 275,000 shares of Relay Therapeutics (a derivative holding)SEC Form 414 January 2025Stock Option (Right to Buy) · traded 10 January 2025 · filed 14 January 2025
- ▼ sold on the open market 299 shares of Relay TherapeuticsSEC Form 431 December 2024Common Stock · traded 27 December 2024 · filed 31 December 2024
- ▼ sold on the open market 4,566 shares of Relay TherapeuticsSEC Form 431 December 2024Common Stock · traded 27 December 2024 · filed 31 December 2024
- ▼ sold on the open market 1,697 shares of Relay TherapeuticsSEC Form 430 October 2024Common Stock · traded 28 October 2024 · filed 30 October 2024
- ▼ sold on the open market 5,105 shares of Relay TherapeuticsSEC Form 430 October 2024Common Stock · traded 28 October 2024 · filed 30 October 2024
- ▼ sold on the open market 2,300 shares of Relay TherapeuticsSEC Form 430 October 2024Common Stock · traded 29 October 2024 · filed 30 October 2024
- ▼ sold on the open market 295 shares of Relay TherapeuticsSEC Form 41 October 2024Common Stock · traded 27 September 2024 · filed 1 October 2024
- ▼ sold on the open market 6,162 shares of Relay TherapeuticsSEC Form 41 October 2024Common Stock · traded 27 September 2024 · filed 1 October 2024
- ▼ sold on the open market 1,702 shares of Relay TherapeuticsSEC Form 431 July 2024Common Stock · traded 29 July 2024 · filed 31 July 2024
- ▼ sold on the open market 9,078 shares of Relay TherapeuticsSEC Form 431 July 2024Common Stock · traded 29 July 2024 · filed 31 July 2024
- ▼ sold on the open market 295 shares of Relay TherapeuticsSEC Form 41 July 2024Common Stock · traded 27 June 2024 · filed 1 July 2024
- ▼ sold on the open market 9,078 shares of Relay TherapeuticsSEC Form 41 July 2024Common Stock · traded 27 June 2024 · filed 1 July 2024
- ▼ sold on the open market 1,695 shares of Relay TherapeuticsSEC Form 429 April 2024Common Stock · traded 29 April 2024 · filed 29 April 2024
- ▼ sold on the open market 348 shares of Relay TherapeuticsSEC Form 429 March 2024Common Stock · traded 27 March 2024 · filed 29 March 2024
- ▼ sold on the open market 2,005 shares of Relay TherapeuticsSEC Form 431 January 2024Common Stock · traded 29 January 2024 · filed 31 January 2024
- was granted 200,000 shares of Relay TherapeuticsSEC Form 418 January 2024Common Stock · traded 16 January 2024 · filed 18 January 2024
- ▼ sold on the open market 294 shares of Relay TherapeuticsSEC Form 429 December 2023Common Stock · traded 27 December 2023 · filed 29 December 2023
- ▼ sold on the open market 1,697 shares of Relay TherapeuticsSEC Form 41 November 2023Common Stock · traded 30 October 2023 · filed 1 November 2023
- ▼ sold on the open market 294 shares of Relay TherapeuticsSEC Form 429 September 2023Common Stock · traded 27 September 2023 · filed 29 September 2023
- ▼ sold on the open market 1,693 shares of Relay TherapeuticsSEC Form 431 July 2023Common Stock · traded 28 July 2023 · filed 31 July 2023
- ▼ sold on the open market 294 shares of Relay TherapeuticsSEC Form 428 June 2023Common Stock · traded 27 June 2023 · filed 28 June 2023
- ▼ sold on the open market 2,012 shares of Relay TherapeuticsSEC Form 41 June 2023Common Stock · traded 28 April 2023 · filed 1 June 2023
- ▼ sold on the open market 863 shares of Relay TherapeuticsSEC Form 41 May 2023Common Stock · traded 28 April 2023 · filed 1 May 2023
- ▼ sold on the open market 347 shares of Relay TherapeuticsSEC Form 428 March 2023Common Stock · traded 27 March 2023 · filed 28 March 2023
- ▼ sold on the open market 864 shares of Relay TherapeuticsSEC Form 431 January 2023Common Stock · traded 30 January 2023 · filed 31 January 2023
- was granted 104,600 shares of Relay Therapeutics (a derivative holding)SEC Form 419 January 2023Stock Option (Right to Buy) · traded 17 January 2023 · filed 19 January 2023
- was granted 97,630 shares of Relay Therapeutics (a derivative holding)SEC Form 419 January 2023Stock Option (Right to Buy) · traded 17 January 2023 · filed 19 January 2023
- was granted 101,115 shares of Relay TherapeuticsSEC Form 419 January 2023Common Stock · traded 17 January 2023 · filed 19 January 2023
- ▼ sold on the open market 445 shares of Relay TherapeuticsSEC Form 428 December 2022Common Stock · traded 27 December 2022 · filed 28 December 2022
- ▼ sold on the open market 1,099 shares of Relay TherapeuticsSEC Form 41 November 2022Common Stock · traded 28 October 2022 · filed 1 November 2022
- ▼ sold on the open market 443 shares of Relay TherapeuticsSEC Form 429 September 2022Common Stock · traded 27 September 2022 · filed 29 September 2022
- exercised options over 26,257 shares of Relay Therapeutics (a derivative holding)SEC Form 48 September 2022Stock Option (Right to Buy) · traded 8 September 2022 · filed 8 September 2022
- exercised options over 26,257 shares of Relay TherapeuticsSEC Form 48 September 2022Common Stock · traded 8 September 2022 · filed 8 September 2022
- ▼ sold on the open market 26,257 shares of Relay TherapeuticsSEC Form 48 September 2022Common Stock · traded 8 September 2022 · filed 8 September 2022
- ▼ sold on the open market 734 shares of Relay TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- ▼ sold on the open market 300 shares of Relay TherapeuticsSEC Form 428 June 2022Common Stock · traded 27 June 2022 · filed 28 June 2022
- ▼ sold on the open market 725 shares of Relay TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 282 shares of Relay TherapeuticsSEC Form 431 March 2022Common Stock · traded 29 March 2022 · filed 31 March 2022
- exercised options over 13,286 shares of Relay Therapeutics (a derivative holding)SEC Form 428 March 2022Stock Option (Right to Buy) · traded 24 March 2022 · filed 28 March 2022
- exercised options over 13,286 shares of Relay TherapeuticsSEC Form 428 March 2022Common Stock · traded 24 March 2022 · filed 28 March 2022
- ▼ sold on the open market 13,286 shares of Relay TherapeuticsSEC Form 428 March 2022Common Stock · traded 24 March 2022 · filed 28 March 2022
- was granted 78,540 shares of Relay Therapeutics (a derivative holding)SEC Form 431 January 2022Stock Option (Right to Buy) · traded 27 January 2022 · filed 31 January 2022
- was granted 39,270 shares of Relay TherapeuticsSEC Form 431 January 2022Common Stock · traded 27 January 2022 · filed 31 January 2022
- ▼ sold on the open market 295 shares of Relay TherapeuticsSEC Form 427 December 2021Common Stock · traded 27 December 2021 · filed 27 December 2021
- exercised options over 22,500 shares of Relay Therapeutics (a derivative holding)SEC Form 416 November 2021Stock Option (Right to Buy) · traded 15 November 2021 · filed 16 November 2021
- exercised options over 22,500 shares of Relay TherapeuticsSEC Form 416 November 2021Common Stock · traded 15 November 2021 · filed 16 November 2021
- ▼ sold on the open market 22,500 shares of Relay TherapeuticsSEC Form 416 November 2021Common Stock · traded 15 November 2021 · filed 16 November 2021
- ▼ sold on the open market 293 shares of Relay TherapeuticsSEC Form 427 September 2021Common Stock · traded 27 September 2021 · filed 27 September 2021
- exercised options over 22,500 shares of Relay Therapeutics (a derivative holding)SEC Form 413 September 2021Stock Option (Right to Buy) · traded 13 September 2021 · filed 13 September 2021
- exercised options over 22,500 shares of Relay TherapeuticsSEC Form 413 September 2021Common Stock · traded 13 September 2021 · filed 13 September 2021
- ▼ sold on the open market 22,500 shares of Relay TherapeuticsSEC Form 413 September 2021Common Stock · traded 13 September 2021 · filed 13 September 2021
- ▼ sold on the open market 293 shares of Relay TherapeuticsSEC Form 430 June 2021Common Stock · traded 28 June 2021 · filed 30 June 2021
- exercised options over 22,500 shares of Relay TherapeuticsSEC Form 49 June 2021Common Stock · traded 30 March 2021 · filed 9 June 2021
- ▼ sold on the open market 22,500 shares of Relay TherapeuticsSEC Form 49 June 2021Common Stock · traded 30 March 2021 · filed 9 June 2021
- exercised options over 22,500 shares of Relay Therapeutics (a derivative holding)SEC Form 49 June 2021Stock Option (Right to Buy) · traded 30 March 2021 · filed 9 June 2021
- exercised options over 22,500 shares of Relay TherapeuticsSEC Form 49 June 2021Common Stock · traded 7 June 2021 · filed 9 June 2021
- ▼ sold on the open market 22,500 shares of Relay TherapeuticsSEC Form 49 June 2021Common Stock · traded 7 June 2021 · filed 9 June 2021
- exercised options over 22,500 shares of Relay Therapeutics (a derivative holding)SEC Form 49 June 2021Stock Option (Right to Buy) · traded 7 June 2021 · filed 9 June 2021
- exercised options over 22,500 shares of Relay TherapeuticsSEC Form 41 April 2021Common Stock · traded 30 March 2021 · filed 1 April 2021
- ▼ sold on the open market 22,500 shares of Relay TherapeuticsSEC Form 41 April 2021Common Stock · traded 30 March 2021 · filed 1 April 2021
- exercised options over 22,500 shares of Relay Therapeutics (a derivative holding)SEC Form 41 April 2021Stock Option (Right to Buy) · traded 30 March 2021 · filed 1 April 2021
- was granted 15,870 shares of Relay TherapeuticsSEC Form 426 March 2021Common Stock · traded 26 March 2021 · filed 26 March 2021
- was granted 31,740 shares of Relay Therapeutics (a derivative holding)SEC Form 426 March 2021Stock Option (Right to Buy) · traded 26 March 2021 · filed 26 March 2021
- was granted 63,363 shares of Relay Therapeutics (a derivative holding)SEC Form 415 December 2020Stock Option (Right to Buy) · traded 11 December 2020 · filed 15 December 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.